The FDA has given accelerated approval to a groundbreaking T cell-based therapy from Adaptimmune for synovial sarcoma, becoming the first new treatment for the rare soft tissue cancer in more than ...

‘Definitive diagnosis of synovial sarcoma can be challenging, even after tissue sampling. Immunohistochemistry can be helpful but insufficient as the tumor can histologically resemble other soft ...